New Delhi, India: Zydus Cadila, a pharmaceutical company, said on Monday that it has obtained final clearance from the US Food and Drug Administration to commercialise Tofacitinib extended-release tablets, which are used to treat rheumatoid arthritis. The medication has been approved by the US Food and Drug Administration (USFDA) in 11 mg and 22 mg doses, according to the firm.
According to Zydus, the firm was the first to file an abbreviated new drug application (ANDA) for Tofacitinib extended-release tablets 22 mg and so has 180-day exclusivity on this strength.
New Delhi, India: Zydus Cadila, a pharmaceutical company, said on Monday that it has obtained final clearance from the US Food and Drug Administration to commercialise Tofacitinib extended-release tablets, which are used to treat rheumatoid arthritis. The medication has been approved by the US Food and Drug Administration (USFDA) in 11 mg and 22 mg doses, according to the firm.
According to Zydus, the firm was the first to file an abbreviated new drug application (ANDA) for Tofacitinib extended-release tablets 22 mg and so has 180-day exclusivity on this strength.
https://youtu.be/mlBSCMO2NQg?si=UfC4C3WgtMZ9DhB4 Humans Are Swallowing Microplastics: A Hidden Environmental and Health Crisis In recent years, microplastics…
https://youtu.be/H_aiXVvX8Eg?si=vH4Arvq7pbpXERMF Obesity Drugs: A Comprehensive Guide to Weight Loss Solutions Obesity is one of the…
https://youtu.be/LZi8Jn0tAA8?si=bpMPudQxl1LUdgXN Cold Hands & Feet in Winter: Causes, Remedies, and Prevention Tips Winter can be…
Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…
https://youtu.be/mdl3AFFFcuk?si=i2cYzTX7WJ-z6wRp Does Chyawanprash Help in Cough & Cold? Exploring Its Benefits and Efficacy Chyawanprash, a…
Walk In Winter: In winter, the time from 7:00 AM to 9:00 AM is considered…